![]() |
|
||||||||||
News ReleasesSelect Access™ to Co-Promote Asthma TreatmentOne Year Agreement Is To Assist Emerging Pharma Client Improve Presence Saddle River, NJ— (September, 2006) PDI, Inc. (NASDAQ: PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, has announced that its Select Access™ unit has been awarded a one-year contract to co-promote an inhaled agent for the treatment of asthma. Unable to secure better than a third position with their own field force, the client has engaged Select Access to reach primary care physicians and allergists in high prescribing national zip codes, where the product will be in primary position 70% of the time. Select Access™ has a unique selling model where multiple, non-competitive clients can access a fully operational sales force in high prescribing zip codes and first detail position. Since the sales team, and its cost, are leveraged across multiple clients, Select Access™ is effective for over-the-counter; and Rx established, seasonal and specialty products “Many times our clients are unable to achieve first detail position within their own sales force,” said Nancy Connelly, Senior Vice President and General Manager of Select Access. “They find our model particularly attractive because they can gain first position calls to their most important targets at a leveraged price point that makes is very affordable for them to optimize their brand.” About Select Access Select Access, a targeted sales solution for a diverse group of pharmaceutical products, leverages an existing infrastructure to maximize brand profitability. Rapid deployment and national coverage by approximately 350 experienced sales representatives in high prescribing territories increases speed to impact. Select Access™ is the only alternative sales force model that gives clients complete target audience control and flexibility and where the majority of sales calls are single detail. Select Access' unmatched value is perfectly aligned to increase incremental revenue for seasonal, established, and OTC brands, and for specialty brands that could gain an additional revenue stream from a primary care presence. About PDI PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry offering a comprehensive set of outsourced sales and marketing solutions for established and emerging pharmaceutical companies. PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance. For more information contact: Copyright © Select Access, a division of PDI, Inc. • Information Privacy Policy About Select Access | Markets Served | Press & Media | Target Coverage Analysis | Contact Us | PDI, Inc. |
|